作者：
Martina,Zátopková [1]
;
Tereza,Ševčíková [2]
;
Viola,Fanfani [3]
;
Zuzana,Chyra [1]
;
Lucie,Říhová [2]
;
Renata,Bezděková [3]
;
David,Žihala [4]
;
Kateřina,Growková [1]
;
Jana,Filipová [2]
;
Lucie,Černá [5]
;
Lucie,Broskevičova [6]
;
Fedor,Kryukov [6]
;
Jiří,Minařík [1]
;
Jana,Smejkalová [2]
;
Vladimír,Maisnar [3]
;
Ĺubica,Harvanová [1]
;
Luděk,Pour [2]
;
Alexandra,Jungova [3]
;
Tereza,Popková [1]
;
Juli Rodriguez,Bago [1]
;
Anjana,Anilkumar Sithara [2]
;
Matouš,Hrdinka [7]
;
Tomáš,Jelínek [8]
;
Michal,Šimíček [2]
;
Giovanni,Stracquadanio [9]
;
Roman,Hájek [10]
作者单位：
Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
[1]
Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
[2]
Department of Biology and Ecology, University of Ostrava, Ostrava, Czech Republic.
[3]
Institute of Quantitative Biology, Biochemistry and Biotechnology, University of Edinburgh, Edinburgh, United Kingdom.
[4]
Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
[5]
Department of Clinical Hematology, University Hospital Brno, Brno, Czech Republic.
[6]
Clinical Development Department, Joint-stock Company BIOCAD, Saint Petersburg, Russia.
[7]
Department of Hematooncology, University Hospital and Palacky University Olomouc, Olomouc, Czech Republic.
[8]
4th Department of Medicine-Haematology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
[9]
Department of Hematology and Transfusiology, University Hospital Bratislava, Bratislava, Slovakia.
[10]
Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic; and.
[11]
Department of Hemato-Oncology, Charles University Hospital Pilsen, Pilsen, Czech Republic.
[12]
DOI
10.1182/bloodadvances.2020003876
PMID
34500459
发布时间
2022-06-07
换一批
换一批
